sever
acut
respiratori
syndrom
sar
first
report
novemb
rapidli
spread
number
distant
global
region
earli
new
coronaviru
sarscov
identifi
caus
sar
rapidli
sequenc
character
sarscov
envelop
posit
strand
rna
viru
wide
host
rang
recombin
mutat
rate
rna
virus
high
sever
order
magnitud
higher
dna
base
microb
eukaryot
caus
rapid
chang
antigen
virul
drug
sensit
thu
direct
estim
mutat
rate
sarscov
human
popul
analysi
mutat
spectrum
would
aid
develop
strategi
monitor
therapi
previous
analysi
sar
sequenc
five
origin
singapor
may
indic
two
differ
genotyp
circul
world
recent
substanti
increas
number
sarscov
genom
sequenc
total
sarscov
genom
sequenc
public
databas
prior
octob
sequenc
within
institut
use
current
analysi
larg
dataset
coupl
avail
clinic
data
case
relat
singapor
patient
molecular
observ
vitro
cell
passag
present
opportun
comprehens
analysi
sarscov
mutat
behavior
sarscov
primari
patient
tissu
isol
homogen
tissu
pb
buffer
follow
low
speed
centrifug
obtain
viral
particl
contain
supernat
viruscontain
sampl
also
inocul
vero
cell
cell
maintain
use
usual
viral
cell
cultur
media
repassag
day
incub
viruscontain
supernat
homogen
differ
passag
vero
cell
show
cpe
centrifug
rcf
hour
pellet
viral
particl
follow
rna
extract
use
qiamp
viral
rna
mini
kit
qiagen
rna
genom
templat
convert
doubl
strand
cdna
sequenc
previous
describ
process
raw
sequenc
read
base
call
assembl
edit
done
use
phredphrapcons
univers
washington
seattl
wa
usa
number
singl
nucleotid
variat
snv
confirm
use
sensit
mass
spectrometri
base
genotyp
assay
develop
within
institut
rna
viru
first
isol
use
qiamp
viral
rna
mini
kit
reversetranscrib
cdna
use
rna
templat
superscript
kit
invitrogen
sequenc
specif
primer
purifi
primer
extens
assay
carri
snv
interest
extens
product
detect
massarray
sequenom
determin
genotyp
align
sarscov
genom
use
clustalw
minim
effect
sequenc
error
artefact
analysi
employ
filter
scheme
snv
share
two
differ
isol
kept
phylogenet
tree
reconstruct
use
filter
variat
reconstruct
done
use
paup
maximum
likelihood
criterion
keep
paramet
default
signific
variat
pass
propos
mutat
filter
mutat
share
isol
consid
real
assess
calcul
probabl
random
nois
would
meet
filter
criterion
null
hypothesi
noisi
variat
gener
independ
genom
let
q
rate
noisi
mutat
genom
base
find
report
earlier
text
conserv
set
ie
two
per
sarscov
genom
probabl
given
nucleotid
noisi
mutat
share
exactli
differ
isol
thu
probabl
given
nucleotid
posit
erron
mutat
share
k
isol
genom
n
base
appli
bonferroni
inequ
probabl
least
one
posit
corrupt
nois
k
time
p
k
n
n
k
case
sarscov
genom
analyz
paper
k
n
henc
pvalu
mutat
satisfi
filter
estim
sarscov
daili
mutat
rate
employ
conserv
constant
mutat
rate
model
number
mutat
found
isol
ancestor
proport
mutat
rate
k
tempor
differ
isol
ancestor
k
base
singapor
patient
contact
trace
inform
see
figur
obtain
pair
isol
known
definit
ancestordescend
relationship
calcul
number
mutat
time
differ
pair
estim
mutat
rate
k
model
use
least
squar
fit
goodnessoffit
measur
use
adjust
rsquar
statist
anoth
pertin
question
analysi
sarscov
evolut
predict
possibl
date
origin
human
sarscov
base
animalorigin
hypothesi
sarscov
assum
sarscov
isol
palm
civet
cat
put
princip
isol
infect
human
popul
adher
constant
mutat
rate
model
fit
follow
model
dx
kx
k
daili
rate
mutat
x
sampl
date
measur
rel
novemb
dx
number
mutat
compar
civet
cat
isol
isol
sampl
date
x
twelv
data
point
calcul
use
fit
model
date
origin
solv
solv
x
dx
goodnessoffit
measur
use
adjust
rsquar
statist
first
sought
determin
rate
mutat
sarscov
vero
cell
cultur
achiev
subject
isol
passag
vero
cell
appear
cytolysi
passag
sampl
withdrawn
genom
complet
sequenc
ambigu
capillari
sequenc
clarifi
mass
spectroscop
valid
result
show
vero
cell
passag
actual
compris
two
coexist
quasispeci
bear
either
g
posit
mutat
emerg
upon
passag
ratio
ag
remain
constant
passag
tabl
suggest
mutat
rate
cultur
sarscov
low
passag
thu
artifici
mutat
limit
vitro
cell
cultur
neglig
next
ask
whether
transit
human
tissu
growth
vero
cell
cultur
engend
either
mutat
clonal
select
sarscov
sequenc
three
human
tissuevero
cell
cultur
pair
viral
sampl
singapor
one
pair
obtain
public
domain
see
supplement
inform
tabl
result
shown
tabl
show
mutat
emerg
one
case
human
vero
cell
passag
post
genbank
none
singapor
pair
howev
viral
sequenc
isol
lung
sampl
show
evid
coinfect
two
distinct
genotyp
sar
cov
manifest
simultan
presenc
c
posit
confirm
genotyp
use
malditof
massarray
technolog
subsequ
deconvolut
trace
haplotyp
loci
differ
singaporean
isol
reveal
probabl
sequenc
signatur
c
locat
one
isol
c
c
see
tabl
though
tissuederiv
two
sarscov
quasispeci
isol
subsequ
vero
cell
cultur
show
one
bear
c
haplotyp
supplement
inform
tabl
result
show
coinfect
multipl
quasispeci
uncommon
human
tissu
passag
vero
cell
may
either
gener
new
mutat
low
rate
titrat
one
quasispeci
transit
singapor
encount
unusu
incid
stabl
lab
sarscov
isol
commonli
use
vitro
experiment
accident
infect
laboratori
worker
sequenc
origin
laboratori
isol
sinwnv
see
tabl
viral
sampl
directli
patient
sputum
see
tabl
found
sequenc
differ
two
virus
reconfirm
mutat
rate
singl
point
sourc
viru
low
mutat
rate
expand
human
infect
infer
phylogenet
relationship
known
sarscov
isol
use
exist
public
data
problemat
potenti
sequenc
error
moreov
rate
sarscov
mutat
cultur
previous
known
thought
signific
given
mutat
rate
rna
virus
experi
provid
inform
potenti
caus
rate
sequenc
variat
sarscov
cultur
base
vero
cell
passag
humantovero
transit
data
estim
one
sequenc
variat
origin
tissu
viru
account
vitro
cultur
artifact
averag
basecal
error
probabl
report
phrep
sequenc
error
per
sarscov
genom
accordingli
suspect
sequenc
error
report
sar
sequenc
would
approxim
base
per
report
genom
use
inform
assess
true
sequenc
variant
report
public
sar
sequenc
databas
employ
mutat
filter
mutat
filter
identifi
sequenc
variant
probabl
mutat
appear
one
isol
higher
filter
stringenc
appli
demand
sequenc
variant
present
two
three
isol
total
isol
analyz
includ
singapor
result
show
number
mutat
appear
one
isol
high
see
supplementari
tabl
howev
mutat
present
two
isol
much
lower
appear
rel
stabl
figur
statist
analysi
confirm
probabl
find
fals
mutat
share
two
isol
low
p
compar
probabl
find
fals
mutat
share
one
isol
p
result
consist
error
estim
outlin
test
biolog
valid
approach
examin
mutat
frequenc
known
gene
sar
genom
import
proteas
polymeras
viral
replic
suspect
true
nonsynonym
mutat
sarscov
present
clinic
sampl
might
rare
two
orf
comparison
structur
gene
encod
n
protein
without
mutat
filter
sequenc
variat
commonli
observ
proteas
polymeras
gene
howev
mutat
identifi
variant
seen
two
isol
mutat
detect
critic
proteas
polymeras
gene
wherea
mutat
note
n
gene
regardless
filter
stringenc
figur
therefor
determin
effect
mutat
filter
presenc
sequenc
variant
two
isol
use
filter
stringenc
assess
phylogenet
relationship
isol
describ
recent
sar
epidem
urbani
form
core
earli
isol
employ
root
four
major
cluster
appear
two
singaporean
branch
one
taiwan
branch
one
north
china
branch
figur
valid
cluster
two
sequenc
germani
frankfurt
fra
group
singaporean
branch
actual
deriv
singaporean
doctor
treat
patient
later
hospit
frankfurt
singaporean
case
form
one
molecular
subbranch
match
contact
trace
figur
clinic
contact
trace
data
ambigu
direct
sourc
exposur
intriguingli
howev
root
second
subbranch
within
singapor
origin
probabl
hotel
cluster
suggest
potenti
direct
infect
hotel
sourc
use
contact
trace
inform
calcul
averag
mutat
rate
human
transmiss
two
mutat
per
human
transmiss
obtain
precis
date
symptom
onset
singaporean
case
tabl
use
common
mutat
identifi
applic
mutat
filter
employ
constant
mutat
rate
model
estim
mutat
rate
sarscov
recent
epidem
estim
mutat
rate
nucleotid
per
day
nucleotid
substitut
per
site
per
day
adjust
rsquar
valu
fit
model
rate
synonym
nonsynonym
mutat
equival
nucleotid
substitut
per
site
per
day
respect
use
singapor
isol
known
date
onset
use
genom
isol
palm
civet
cat
put
origin
sarscov
jump
anim
human
calcul
daili
substitut
rate
nucleotid
per
day
nucleotid
substitut
per
site
per
day
adjust
rsquar
estim
possibl
date
emerg
oct
overal
mutat
rate
sarscov
appear
consist
report
rate
virus
mutat
analysi
also
reveal
separ
delet
one
insert
distinguish
differ
isol
figur
intriguingli
cluster
within
short
bp
region
end
viral
genom
span
put
orf
sar
sar
despit
overlap
natur
delet
descend
relationship
amongst
addit
insertiondelet
inform
add
cluster
assumpt
therefor
region
rel
instabl
dispens
viral
replic
focu
investig
measur
mutat
frequenc
dynam
vitro
vivo
sarscov
find
suggest
overal
sarscov
rate
mutat
cultur
low
inocul
human
sarscov
vero
cell
introduc
averag
less
one
nucleotid
mutat
subsequ
cultur
sarscov
infect
vero
cell
induc
less
one
nucleotid
mutat
five
consecut
vero
cell
passag
mutat
also
observ
infect
sarscov
cultur
vero
cell
human
would
consist
notion
sarscov
isol
patient
gave
rise
vitro
line
well
adapt
vitro
growth
propos
mutat
filter
base
observ
seem
stabl
effect
use
filter
reconstruct
molecular
phylogenet
relat
sarscov
genom
reveal
least
three
major
branch
compos
case
relat
hotel
hong
kong
case
report
north
china
case
found
taiwan
moreov
show
molecular
sequenc
associ
effect
use
precis
reconstruct
contact
trace
estim
daili
substitut
rate
sarscov
nucleotid
nucleotid
substitut
per
site
mutat
rate
similar
rna
virus
take
sarscov
isol
palm
civet
cat
put
origin
sarscov
calcul
suggest
earliest
possibl
date
sar
emerg
predict
oct
final
prepar
manuscript
two
report
publish
address
mutat
rate
sarscov
human
popul
yeh
et
al
examin
taiwanes
sar
sampl
estim
cov
mutat
rate
nucleotid
per
site
per
day
chines
sar
molecular
epidemiolog
consortium
examin
larger
number
viral
isol
recent
determin
mutat
rate
nucleotid
per
site
per
day
use
sampl
china
estim
close
addit
chines
consortium
project
time
emerg
sar
cov
epidem
novemb
remark
consensu
three
studi
use
differ
patient
popul
mutat
dynam
sar
cov
suggest
result
bona
fide
none
declar
vbv
etl
perform
data
analysi
prepar
draft
manuscript
stsi
lae
provid
sarscov
sampl
patient
vero
cell
kft
oee
provid
continu
sarscov
contain
vero
cell
passag
sampl
yr
lw
design
experi
coordin
sampl
acquir
viral
genom
sequenc
clw
tz
gener
dna
sequenc
data
whl
process
dna
sequenc
assembl
viral
genom
jl
verifi
sequenc
variat
conduct
malditof
mass
spectrometri
analysi
pk
assess
effect
nucleotid
variat
orf
protein
vbv
pml
carri
mathemat
statist
analysi
prepubl
histori
paper
access
